Pasithea shareholders approve reverse stock split up to 1:20; re-elect two directors

Pasithea Therapeutics Corp.

Annual meeting held Sept 9, 2026; quorum of 26,142,328 of 33,414,448 shares represented.
Dr. Tiago Reis Marques re-elected with 18,381,039 votes for; Prof. Lawrence Steinman with 17,000,205.
Ratified CBIZ as independent auditor for FY2026: 25,935,574 for, 199,988 against.
Approved reverse stock split amendment (1:2 to 1:20) with 25,071,052 for, 1,053,169 against; board sets exact ratio.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.